Prevalence of contact dermatitis to glucose sensors in pediatric population and the main allergens involved

2020 ◽  
Vol 83 (1) ◽  
pp. 47-49 ◽  
Author(s):  
Carmen Vidal‐Albareda ◽  
Rosa Yelmo‐Valverde ◽  
Cristiana Solórzano‐Zepeda ◽  
Noris Rodríguez‐Muñoz ◽  
Belén de‐la‐Hoz‐Caballer ◽  
...  
Author(s):  
Ulrik Ahrensbøll‐Friis ◽  
Anne Birgitte Simonsen ◽  
Claus Zachariae ◽  
Jacob P. Thyssen ◽  
Jeanne D. Johansen

1993 ◽  
Vol 14 (6) ◽  
pp. 240-243 ◽  
Author(s):  
Peter A. Hogan ◽  
William L. Weston

Definition Allergic contact dermatitis (ACD) is an inflammatory reaction of the skin that follows percutaneous absorption of antigen from the skin surface and recruitment of previously sensitized, antigen-specific T lymphocytes into the skin. Epidemiology In the pediatric age group, ACD can involve either sex and manifest as early as the first week of life. A recent review of several European and US studies found that ACD may account for up to 20% of cases of dermatitis in the 0- to 14-year-old age group. Although the incidence and prevalence of the disease in the general pediatric population is unknown, epicutaneous patch testing of randomly selected and otherwise healthy children revealed that 13% to 20% were allergic to one or more common antigens, suggesting that at least 20% of children in the general population theoretically are at risk of developing ACD. When one considers poison ivy or poison oak as contact allergens prevalent in certain areas of North America, the likelihood of allergic contact dermatitis may be much higher. Pediatricians should recognize that children are sensitized to contact allergens early in life, with most children being sensitized by age 5 years. The allergens most commonly responsible for allergic contact dermatitis in North American children are listed in Table 1.


2020 ◽  
Vol 83 (4) ◽  
pp. 301-309 ◽  
Author(s):  
Josefin Ulriksdotter ◽  
Cecilia Svedman ◽  
Magnus Bruze ◽  
Jenny Glimsjö ◽  
Kajsa Källberg ◽  
...  

2019 ◽  
Vol 82 (2) ◽  
pp. 105-111 ◽  
Author(s):  
Anne Herman ◽  
Anne‐Sophie Darrigade ◽  
Laurence Montjoye ◽  
Marie Baeck

2021 ◽  
Author(s):  
María E. Gatica‐Ortega ◽  
Martin Mowitz ◽  
María A. Pastor‐Nieto ◽  
Francisco J. Navarro‐Triviño ◽  
Virginia Fernández‐Redondo ◽  
...  

2019 ◽  
Vol 81 (3) ◽  
pp. 161-166 ◽  
Author(s):  
Heli S. I. Hyry ◽  
Jussi P. Liippo ◽  
Hannele M. Virtanen

Author(s):  
JB Joyanes Romo ◽  
JM Borja Segade ◽  
L Moreno Lozano ◽  
R García Rodríguez ◽  
OM González Jiménez ◽  
...  

2019 ◽  
Vol 99 (13) ◽  
pp. 1286-1287
Author(s):  
M Mowitz ◽  
L Fornander ◽  
S Hosseiny ◽  
K Ryberg ◽  
M Bruze

Author(s):  
Lorna K. Mayo ◽  
Kenneth C. Moore ◽  
Mark A. Arnold

An implantable artificial endocrine pancreas consisting of a glucose sensor and a closed-loop insulin delivery system could potentially replace the need for glucose self-monitoring and regulation among insulin dependent diabetics. Achieving such a break through largely depends on the development of an appropriate, biocompatible membrane for the sensor. Biocompatibility is crucial since changes in the glucose sensors membrane resulting from attack by orinter action with living tissues can interfere with sensor reliability and accuracy. If such interactions can be understood, however, compensations can be made for their effects. Current polymer technology offers several possible membranes that meet the unique chemical dynamics required of a glucose sensor. Two of the most promising polymer membranes are polytetrafluoroethylene (PTFE) and silicone (Si). Low-voltage scanning electron microscopy, which is an excellent technique for characterizing a variety of polymeric and non-conducting materials, 27 was applied to the examination of experimental sensor membranes.


Sign in / Sign up

Export Citation Format

Share Document